Partially cystic thyroid nodules (PCTNs) are frequently underestimated in clinical practice and managed conservatively, potentially increasing the risk of cervical lymph node metastasis. This study aims to explore the contrast-enhanced ultrasound features associated with malignancy in PCTNs.
Methods
This retrospective study included 94 PCTNs from 87 patients in the Second Hospital of Lanzhou University between January 2019 and December 2024. Conventional ultrasound, contrast-enhanced ultrasound (CEUS) features, and clinical data of the nodules were analyzed. Using pathological diagnosis as the gold standard, univariate and multivariate logistic regression analyses were conducted to identify independent predictors of malignancy in PCTNs. A predictive model was subsequently developed, and its diagnostic performance was assessed using receiver operating characteristic (ROC) curve analysis.
Results
Centrifugal perfusion, an ill-defined enhancement boundary, faster washout, and the absence of a peripheral high-enhancement ring are independent predictors of malignant PCTNs. The resulting predictive model exhibited excellent diagnostic performance for PCTNs, with a sensitivity of 92.7%, a specificity of 92.5%, a Youden index of 0.852, and an AUC of 0.968.
Conclusions
CEUS features are valuable in differentiating malignant nodules from benign PCTNs, improving physicians’ diagnostic confidence in distinguishing benign and malignant PCTNs, and assisting clinicians in clinical decision-making.
MehannaHNankivellPBoelaertK, et al.Diagnostic performance of ultrasound vs ultrasound-guided FNAC in thyroid nodules: data from the ElaTION trial. J Clin Endocrinol Metab2025; 110: 1997–2006.
2.
KallepalliVSDNelsonTSanniyasiS. Analysis of thyroid imaging reporting and data system criteria and its correlation with the pathological results. Cureus2023; 15: e40117.
3.
UludagMUnluMTKostekM, et al.Management of thyroid nodules. Sisli Etfal Hastan Tip Bul2023; 57: 287–304.
4.
TodsenTEwertsenCJenssenC, et al.Head and neck ultrasound - EFSUMB training recommendations for the practice of medical ultrasound in Europe. Ultrasound Int Open2022; 8: E29–e34.
5.
ZhouTHuTNiZ, et al.Comparative analysis of machine learning-based ultrasound radiomics in predicting malignancy of partially cystic thyroid nodules. Endocrine2024; 83: 118–126.
6.
ShenRChengRZhouH, et al.Ultrasonography-guided radiofrequency ablation combined with lauromacrogol sclerotherapy for mixed thyroid nodules. Am J Transl Res2021; 13: 5035–5042.
7.
XinYLiuFShiY, et al.A scoring system for assessing the risk of malignant partially cystic thyroid nodules based on ultrasound features. Front Oncol2021; 11: 731779.
8.
LukinovićJBilićM. Overview of thyroid surgery complications. Acta Clin Croat2020; 59: 81–86.
9.
BaileyGEAzadiJRussellJO, et al.Ultrasound-guided thyroid fine-needle aspiration and concurrent core needle biopsy: a comparative study with practical clinical scenarios. Am J Clin Pathol2025; 164: 500–512.
10.
LebrunLSalmonI. Pathology and new insights in thyroid neoplasms in the 2022 WHO classification. Curr Opin Oncol2024; 36: 13–21.
11.
CapitoliGPigaIL'imperioV, et al.Cytomolecular classification of thyroid nodules using fine-needle washes aspiration biopsies. Int J Mol Sci2022; 23: 4156.
12.
AliSZBalochZWCochand-PriolletB, et al.The 2023 Bethesda system for reporting thyroid cytopathology. Thyroid2023; 33: 1039–1044.
13.
Al-YousofyFHamoodMAlmataryAM, et al.Accuracy of ultrasound-guided fine-needle aspiration cytology in evaluation of thyroid nodules using different ultrasonographic and cytological features. Cytopathology2024; 35: 738–748.
14.
DolidzeDDCovantsevSChecheninGM, et al.Core needle biopsy for thyroid nodules assessment-a new horizon?World J Clin Oncol2024; 15: 580–586.
15.
DietrichCFCorreasJ-MCuiX-W, et al.EFSUMB Technical review – update 2023: dynamic contrast-enhanced ultrasound (DCE-CEUS) for the quantification of tumor perfusion. Ultraschall in der Medizin - European Journal of Ultrasound2023; 45: 36–46.
16.
DietrichCFAlbrechtTBecherH, et al.History of contrast enhanced ultrasound (CEUS). Med Ultrason2024; 26: 05.
17.
PepinEWNordeckSMFetzerDT. Nontraditional uses of US contrast agents in abdominal imaging and intervention. Radiographics2022; 42: 1724–1741.
18.
NegrãoDEFigueiredoGMüller-PeltzerK, et al.[CEUS-Diagnostic of malignant liver lesions]. Radiologe2018; 58: 528–537.
19.
DietrichCFNolsøeCPBarrRG, et al.Guidelines and good clinical practice recommendations for contrast-enhanced ultrasound (CEUS) in the liver-update 2020 WFUMB in cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. Ultrasound Med Biol2020; 46: 2579–2604.
20.
ŻyłkaADobruch-SobczakKPiotrzkowska-WróblewskaH, et al.The utility of contrast-enhanced ultrasound (CEUS) in assessing the risk of malignancy in thyroid nodules. Cancers (Basel)2024; 16: 1911.
GolematiSCokkinosDD. Recent advances in vascular ultrasound imaging technology and their clinical implications. Ultrasonics2022; 119: 106599.
24.
SidhuPSCantisaniVDietrichCF, et al.The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (long version). Ultraschall Med2018; 39: e2–e44.
25.
SorrentiSDolcettiVFresilliD, et al.The role of CEUS in the evaluation of thyroid cancer: from diagnosis to local staging. J Clin Med2021; 10: 4559.
26.
KimSYNaDGPaikW. Which ultrasound image plane is appropriate for evaluating the taller-than-wide sign in the risk stratification of thyroid nodules?Eur Radiol2021; 31: 7605–7613.
27.
Wang CYLiYZhang MM, et al.Analysis of differential diagnosis of benign and malignant partially cystic thyroid nodules based on ultrasound characterization with a TIRADS grade-4a or higher nodules. Front Endocrinol (Lausanne2022; 13: 861070.
28.
JiaWCaiYWangS, et al.Predictive value of an ultrasound-based radiomics model for central lymph node metastasis of papillary thyroid carcinoma. Int J Med Sci2024; 21: 1701–1709.
29.
YeBBLiuYYZhangY, et al.Predicting tall-cell subtype of papillary thyroid carcinomas independently with preoperative multimodal ultrasound. Br J Radiol2024; 97: 1311–1319.
30.
LiuYZhaoYFuJ, et al.Ultrasonographic differentiation and ultrasound-based management of partially cystic thyroid nodules. Arch Endocrinol Metab2021; 65: 336–341.
31.
MarchandJGBienvenu-PerrardMRouxelA, et al.Can back-wall cystic figures of thyroid nodules predict benignity?Eur Thyroid J2026; 15: 41–51.
32.
FuYHuangYLiuY, et al.Analysis of risk factors for intra-cystic hemorrhage in microwave ablation of partially cystic thyroid nodules. Front Endocrinol (Lausanne2023; 14: 1171669.
33.
LinYLiPShiYP, et al.Sequential treatment by polidocanol and radiofrequency ablation of large benign partially cystic thyroid nodules with solid components: efficacy and safety. Diagn Interv Imaging2020; 101: 365–372.
34.
ShiXLiuRGaoL, et al.Diagnostic value of sonographic features in distinguishing malignant partially cystic thyroid nodules: a systematic review and meta-analysis. Front Endocrinol (Lausanne2021; 12: 624409.
35.
ZhouTHuangHDongH, et al.Ultrasound-Based risk stratification system for the assessment of partially cystic thyroid nodules. Endocr Pract2023; 29: 428–435.
36.
LiuRChenHSongJ, et al.Malignant risk assessment of cystic-solid thyroid nodules based on multimodal ultrasound features: a systematic review and meta-analysis. Curr Med Imaging2025; 21: e15734056360924.
37.
ZhouJYinLWeiX, et al.2020 Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules: the C-TIRADS. Endocrine2020; 70: 256–279.
38.
TesslerFNMiddletonWDGrantEG, et al.ACR Thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee. J Am Coll Radiol2017; 14: 587–595.
39.
RussGBonnemaSJErdoganMF, et al.European thyroid association guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults: the EU-TIRADS. Eur Thyroid J2017; 6: 225–237.
40.
HaEJChungSRNaDG, et al.2021 Korean thyroid imaging reporting and data system and imaging-based management of thyroid nodules: Korean society of thyroid radiology consensus statement and recommendations. Korean J Radiol2021; 22: 2094–2123.
41.
ParkJMChoiYKwagHJ. Partially cystic thyroid nodules: ultrasound findings of malignancy. Korean J Radiol2012; 13: 530–535.
42.
ShiYZJinYZhengL. Partially cystic thyroid nodules on ultrasound: the associated factors for malignancy. Clin Hemorheol Microcirc2020; 74: 373–381.
43.
De Araujo-FilhoVJAlvesVADE CastroIV, et al.Vascular endothelial growth factor expression in invasive papillary thyroid carcinoma. Thyroid2009; 19: 1233–1237.
44.
GaoZLuQYanJ. Value of differential diagnosis of contrast-enhanced ultrasound in benign and malignant thyroid nodules with microcalcification. Oncol Lett2019; 17: 4545–4549.
45.
WangGYinCWangY, et al.Contrast-enhanced ultrasound (CEUS) characteristics of atypical-enhanced papillary thyroid carcinoma (PTC). Clin Hemorheol Microcirc2024; 88: 71–79.
46.
FanJTaoLZhanW, et al.Diagnostic value of qualitative and quantitative parameters of contrast-enhanced ultrasound for differentiating differentiated thyroid carcinomas from benign nodules. Front Endocrinol (Lausanne2023; 14: 1240615.
47.
RadzinaMRatnieceMPutrinsDS, et al.Performance of contrast-enhanced ultrasound in thyroid nodules: review of current state and future perspectives. Cancers (Basel2021; 13: 5469.
48.
FangFGongYLiaoL, et al.Value of contrast-enhanced ultrasound in partially cystic papillary thyroid carcinomas. Front Endocrinol (Lausanne2021; 12: 783670.
49.
SongQTianXJiaoZ, et al.Value of conventional ultrasonography with contrast-enhanced ultrasonography in the differential diagnosis of partial cystic thyroid nodules. Ultrasound Med Biol2021; 47: 2494–2501.
50.
PangLYangXZhangP, et al.Development and validation of a nomogram based on multimodality ultrasonography images for differentiating malignant from benign American college of radiology thyroid imaging, reporting and data system (TI-RADS) 3-5 thyroid nodules. Ultrasound Med Biol2024; 50: 557–563.
51.
WangZFShangJZhuY, et al.[Role of contrast-enhanced ultrasound in distinguishing between benign and malignant thyroid nodules with calcification]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao2021; 43: 905–910.
52.
JinZZhuYLeiY, et al.Clinical application of C-TIRADS category and contrast-enhanced ultrasound in differential diagnosis of solid thyroid nodules measuring ≥1cm. Med Sci Monit2022; 28: e936368.
53.
YuanZQuanJYunxiaoZ, et al.Contrast-enhanced ultrasound in the diagnosis of solitary thyroid nodules. J Cancer Res Ther2015; 11: 41–45.
